To include your compound in the COVID-19 Resource Center, submit it here.

Blueprint prices $345M follow-on

Blueprint Medicines Corp. (NASDAQ:BPMC) raised $345 million through the sale of 4.3 million shares

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE